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Photodynamic therapy (PDT) is a method for the treatment of
cancer that involves the administration of systemic or topical
photosensitizing drugs that are preferentially taken up by the
tumour and then activated in the presence of light to cause tissue
destruction (Dougherty, 1988). Photodynamic therapy works by
the generation of singlet oxygen that results in damage to cell
membrane structures, microvascular ischaemia, and tissue
necrosis. Numerous clinical trials of photodynamic therapy have
been conducted over the past decade and PDT has been approved
for clinical use in recurrent bladder carcinomas, obstructing
oesophageal tumours, and early carcinomas of the bladder,
oesophagus, stomach, and tracheobronchial tree. PDT has also
been shown to provide curative treatment of early carcinomas of
the head and neck, including the oral cavity, pharynx, and larynx
(Biel, 1995; Feyh, 1996). Initially PDT was tested in advanced
cancers of the head and neck that were untreatable or refractory
to conventional therapy, however these trials produced only
limited success (Schuller et al, 1984; Wile et al, 1984). A recent
retrospective review of the clinical data available for the treat-
ment of head and neck neoplasia using photodynamic therapy
indicated that complete response rates of 89.5% are achievable
for early squamous cell carcinoma of the head and neck (Biel,
1998). Based on a range of photosensitizers and treatment
modalities, cure rates of 95% and 80% were obtained for carci-
noma in situ and T1 squamous cell carcinoma of the vocal chord
and oral cavity/tongue respectively (follow up 70 months) (Biel,
1998).
Most of the available photosensitizers, until recently, have been
mixtures of porphyrins such as haematoporphyrin derivative and
Photofrin (Quadralogic Technologies, Vancouver, Canada). The
main problem with these first-generation photosensitizers is that of
prolonged skin photosensitivity. Phototoxic incidences of 20–40%
have been reported during follow-up of patients having received
Photofrin, with a mean duration of skin photosensitivity exceeding
6 weeks (Dougherty et al, 1990).
The use of 5-aminolaevulinic acid (ALA) represents a different
strategy in the administration of photosensitizers. ALA itself is not
the photo-active drug, but rather it induces, in situ, the synthesis of
a pure endogenous porphyrin called protoporphyrin IX (PpIX).
The formation of PpIX forms part of the haem synthesis pathway
and all nucleated cells that use oxidative metabolism are probably
capable of forming this photosensitizer. However, malignant tissue
appears to preferentially accumulate PpIX, forming the basis of
photodynamic therapy in cancer (Battle, 1993; Kennedy and
Pottier, 1994). Intravenous ALA is rapidly cleared from the body,
with no PpIX fluorescence within the skin or other body organs
detectable after 24 h (Kennedy et al, 1991).
Because of this reduced phototoxicity and excellent tumour
localizing properties, ALA has been used with great success for
the treatment of several neoplastic diseases, particularly of the
skin, bladder and oral cavity. The results show very good clinical
and cosmetic responses (Peng et al, 1997). However, the effects on
thicker lesions (>1 mm) remain to be improved.
At present, the majority of head and neck tumours are treated
conventionally with either surgery or ionizing radiation, although
newer treatments are under investigation (van Dongen and Snow,
1997). Because many successful forms of cancer treatment rely
upon a combination of treatment modalities, we have therefore
investigated the treatment of head and neck carcinoma cell lines
with various combinations of ionizing radiation and photodynamic
therapy following administration of 5-aminolaevulinic acid.
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Summary Photodynamic therapy (PDT) is a promising treatment modality for head and neck, and other tumours, using drugs activated by
light. A second generation drug, 5-aminolaevulinic acid (5-ALA), is a precursor of the active photosensitizer protoporphyrin IX (PpIX) and has
fewer side-effects and much more transient phototoxicity than previous photosensitizers. We have investigated the effect of 5-ALA mediated
PDT in combination with γ -irradiation on the colony forming ability of several human head and neck tumour cell lines. The effect of treatments
on the DNA cell cycle kinetics was also investigated. Our results indicate that the combination of 5-ALA mediated PDT and γ -irradiation results
in a level of cytotoxicity which is additive and not synergistic. 5-ALA mediated PDT had no discernible effect on DNA cell cycle distributions.
γ -irradiation-induced cell cycle arrest in G2 did not enhance the phototoxicity of 5-ALA. © 2000 Cancer Research Campaign
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Cell lines and culture conditions
The three tumour cell lines used in this study; V134, V175, and SCC-
61, are all human squamous cell carcinoma cell lines derived from
tumours of the head and neck. The SCC-61 cell line, kindly donated
by Dr AC Begg (Amsterdam, The Netherlands), has been previously
described (Weichselbaum et al, 1984, 1988). The V134 (Champion
et al, 1995) and V175 (Champion et al, 1997) cell lines were both
derived at Velindre Hospital from patient tumour biopsy samples.
Tumour cells were maintained as monolayer cultures in Dulbecco’s
Modified Eagles Medium (DMEM, Gibco, Paisley, UK) containing
10% fetal calf serum (Gibco, Paisley, UK), 100 U/ml penicillin
(Sigma, Poole, UK 100 µ g/ml streptomycin (Sigma, Poole, UK), and
0.4 µ g/ml hydrocortisone (Sigma, Poole, UK).
Normal human fibroblasts were derived from skin biopsy
material obtained during breast reduction surgery of non-cancer
patients. Fibroblasts were maintained as monolayer cultures in
DMEM containing 15% fetal calf serum, 100 U/ml penicillin, and
100 µ g/ml streptomycin.
All cells were cultured at 37° C in a humidified atmosphere of
5% CO2 in air. Cells were routinely subcultured by the addition 
of 0.02% trypsin/0.05% EDTA (Sigma, Poole, UK). Experiments
were performed using cells harvested in log phase growth.
Irradiation
All irradiations were performed at room temperature in oxic
conditions using a 137Cs gamma source of 0.66 MeV energy. The
dose rate was 1.2 Gy/min. Irradiations were usually completed
within 15 min. Cells were irradiated as monolayers.
Clonogenic cell survival
Exponentially growing cells were irradiated in 25 cm2 flasks in 
5 ml culture medium. Triplicate flasks were set up for non-irradiated
controls and for each radiation dose and each experiment was
repeated three times. Surviving cells were allowed to grow for 10–14
days prior to fixing and staining. Resultant colonies were fixed in 4%
formaldehyde in PBS and were stained with a 1% solution of crystal
violet. Colonies consisting of more than 50 cells were counted.
Measurement of protoporphyrin IX accumulation
Confluent cell cultures were removed from their flasks by
trypsinization and resuspended in serum supplemented medium to
neutralize the trypsin. The cells were centrifuged at 150G for 
5 min and the pellet resuspended in freshly prepared serum-free
medium containing 1 mMol/l 5-aminolaevulinic acid (ALA,
Sigma, Poole, UK) to give about 1 × 106 cells per 5 ml of medium.
The cell suspensions were placed in 25 cm2 flasks lined with a
layer of 2% agar to prevent the cells attaching to the plastic. A
paired flask of cell suspension in serum-free medium, but with no
ALA was also prepared to act as a control. A 0.5 ml sample cell
suspension was immediately removed from each of the paired
flasks to measure the background fluorescence. Cell suspensions
were incubated in the dark at 37° C in an atmosphere of 5% CO2 in
air. Samples were removed every hour from both sets of flasks to
measure ALA-induced fluorescence. Flasks were gently shaken at
these times but otherwise left undisturbed.
Cellular fluorescence was quantified with a FACScan flow
cytometer (Becton-Dickinson, Oxford, UK). ALA-induced fluo-
rescence was excited with an Argon laser emitting at 488 nm and
emission was collected by a photomultiplier tube after passing
through a 650 nm longpass filter. Data from 5 × 103 cells were
recorded and processed using the LYSIS II software (Becton-
Dickinson, Oxford, UK). Using side- and forward-scatter signals,
debris was excluded from the final data. ALA-induced fluores-
cence was determined at various times by subtracting the fluores-
cence of the control cell suspensions from that of the
ALA-incubated cells. The source of ALA-induced fluorescence
was confirmed to be caused by the accumulation of protopor-
phyrin IX by checking the emission spectra of a sample of ALA-
incubated cells with a standard protoporphyrin IX solution on a
spectrophotometer (Perkin-Elmer, Beaconsfield, UK).
Photodynamic therapy
Exponentially growing cells were incubated for 4 hours in serum-
free medium containing 1 mM/L ALA. An incubation period of 4
hours was chosen as in vivo studies of the fluorescence kinetics of
ALA uptake in an animal model suggested this to be the optimum
(Loh et al, 1993) and was further confirmed by our in vitro studies
described in the present report.
Serum-free medium was used because protoporphyrin IX is
lipophilic and rapidly diffuses out of the cell into medium-
containing serum. The pH of the ALA dissolved in medium was
maintained between 7.2 and 7.6. The cells were then incubated at
37° C in 5% CO2 in the dark. After 4 h of incubation, each flask was
then exposed to light from a tungsten-halogen lamp (Micromark,
London, UK) for a specific time. The total spectral irradiance at the
level of the cells, and in the presence of a water filter, was 50
mW/cm2 (400–750 nm) measured using an Ophir Nova power
meter (Ophir Optronics, Jerusalem, Israel) fitted with a black-body
absorber pyroelectric head. These measurements indicated that the
irradiance was constant over the area occupied by the tissue culture
flask. Ultra violet light was minimal and measured at <1 mW/cm2
with UVA <15 µ W/cm2. Infrared radiation was minimised using a
3.5 cm water filter between the cells and the light source. Flasks
containing medium and exposed to the water-filtered light source for
20 min did not warm by >1° C. Experiments were performed on at
least three separate occasions.
DNA contents
Cell cultures were removed from their flasks by trypsinization and
resuspended in phosphate buffered saline (PBS). 125 µ l of
propidium iodide (0.4 mg/ml)/Triton X-100 (1% v/v) was added to
1 ml of cell suspension together with 50 µ l Ribonuclease A
(Sigma, Poole, UK 10 mg/ml). Cells were incubated at 37° C for
10 min prior to analysis with a FACScan flow cytometer (Becton-
Dickinson, Oxford, UK). Propidium iodide fluorescence was
excited with an Argon laser emitting at 488 nm and emission was
collected by a photomultiplier tube after passing through a 650 nm
longpass filter. Data from 5 × 103 cells were recorded and
processed using the LYSIS II software (Becton-Dickinson,
Oxford, UK). Using side- and forward-scatter signals, debris was
excluded from the final data. Normal human lymphocytes were
used to monitor instrument performance and to calibrate measure-
ments of DNA ploidy. Where required, DNA histograms were
deconvoluted according to the protocol of Watson et al (1987) and
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of cells in each of the cell cycle phases (G1, S, G2) to be made.
Clonogenic cell survival following combined PDT and 
γ -irradiation
Exponentially growing cells were irradiated in 25 cm2 flasks in 
5 ml culture medium either 24 hours before or 24 hours following a
single, fixed ‘dose’ of PDT. The light dose used for the PDT was 3
minutes, which from our data resulted in a surviving fraction in the
region of 0.6. Triplicate flasks were set up for non-irradiated controls
and for each radiation dose and each experiment was repeated three
times. Surviving cells were allowed to grow for 10–14 days prior to
fixing and staining. Resultant colonies were fixed in 4% formalde-
hyde in PBS and were stained with a 1% solution of crystal violet.
Colonies consisting of more than 50 cells were counted.
RESULTS
Time-dependent protoporphyrin IX accumulation
All cells incubated in serum-free medium containing 1 mM/l 
ALA over a 24 h time period showed a time dependent increase in
fluorescence. However, flow cytometry of the various cells at 22–24
h showed a wide variation in their side- and forward-scatter signals.
This suggests loss of viability and some degree of cell disintegration
when cells are incubated in serum-free medium for this duration
together with the forced prevention of cell attachment. In the case of
the VB001 normal fibroblasts almost all of the cells were frag-
menting due to apoptosis following the prolonged serum deprivation.
Therefore, all further PDT experiments were performed under
optimal conditions of 4 h incubation in 1 mM/l ALA. The fluores-
cence kinetics of the individual cell lines are summarised in Figure 1.
Clonogenic cell survival following photodynamic
therapy
All of the cell lines examined had a dose-dependent clonogenic
survival response to light, after 4 h of incubation in the presence 
of ALA (Figure 2). The data shown are from pooled experiments
(n ≥ 3). The data were fitted by a linear quadratic function for each
cell line by means of a least squares Marquardt algorithm (Nash,
1979). In order to compare the responsiveness of the cell lines to
ALA-mediated photodynamic therapy we used the surviving frac-
tion following 3 min of PDT as an arbitrary value and termed this
SF3. The SF3 value was derived by solving the equation SF3 =
e(–(α D + β D2)) for D = 3 min of light exposure. A fairly wide vari-
ation in PDT sensitivity was observed in these cell lines with SF3
values of 0.54 (VB001), 0.67 (V134), 0.79 (V175) and 0.68 (SCC-
61). The differing sensitivities were not correlated with the relative
accumulation of protoporphyrin IX by the different cell lines
during the 4 h incubation period.
Cells exposed to ALA but no light showed no increase in cell
death. Similarly, there was no light-dose dependent response in the
absence of ALA.
Clonogenic cell survival following γ -irradiation
The radiation dose–survival curves for the four cell lines are
shown in Figure 3. The data shown are from pooled experiments (n
≥ 3). The data were fitted by a linear quadratic function for each
cell line by means of least squares Marquardt algorithm. Cell line
characteristics and survival curve parameters are shown in Table 1.
In order to compare the in vitro radiosensitivity of the cell lines we
used the surviving fraction following treatment with 2 Gy of
ionizing radiation (SF2) in accordance with previous studies
(Brock et al, 1990; Girinsky et al, 1994; Champion et al, 1997).
The SF-2 value was derived by solving the equation SF2 = e(–(α D
+ β D2)) for D = 2 Gy. A fairly wide variation in radiation sensi-
tivity was observed in these cell lines, with SF2 values of 0.37
(SCC61), 0.61 (V175), 0.54 (V134), and 0.35 (VB001).
DNA cell cycle kinetics following photodynamic
therapy or γ -irradiation
Histograms of cellular DNA content following various treatments
are given in Figure 4. It can be seen that following 8 Gy of radia-
tion the three tumour cell lines (V175, V134, SCC61) exhibit an
accumulation of cells in the G2 phase of the cell cycle, whereas the
normal fibroblasts (VB001) accumulate in both G1 and G2. This
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Figure 1 Fluorescence kinetics of ALA-induced PpIX in the three head and
neck cell lines and the normal fibroblasts used in this study. Data points
represent the geometric mean of 5 × 103 observations of cellular
fluorescence
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Figure 2 Clonogenic cell survival curves for the four cell lines used in this
study, following exposure to 5-ALA-mediated photodynamic therapy. Data
were fitted by a linear quadratic function. In this figure and all subsequent
figures, the error bars represent one standard error of the mean and are
shown if greater than the symbolobservation is consistent with the suggestion that the three tumour
cell lines have aberrant p53 function.
The cell line V134 shows a reduced accumulation in G2
following irradiation compared to the other cell lines and this
correlates with increased radioresistance of this cell line. For the
combination treatment where radiation is given prior to PDT the
V134 showed a much reduced accumulation of cells in G2, indi-
cating that cells are recovering from the cell cycle arrest during the
48 hour period between the initial radiation treatment and DNA
measurement. PDT on its own had no discernible effect on cell
cycle distributions of either tumour or normal cell populations.
Clonogenic cell survival following combined PDT and γ -
irradiation
In order to investigate the cumulative effects of PDT and γ -irradia-
tion on the cell lines, a fixed ‘dose’ of PDT was given either 24 hours
before, or 24 hours following various doses of γ -irradiation. The light
dose used for the PDT was 3 minutes, which from the above data
resulted in a surviving fraction in the region of 0.6. The 24 hour delay
between treatments was to allow any cell cycle arrest to be maxi-
mally in place before the cells underwent the second treatment.
The combined PDT/radiation-dose–survival curves for the four
cell lines are shown in Figure 5. The data shown are from pooled
experiments (n ≥ 3). The data were fitted by a linear quadratic
function as described above. Also shown on the figure are the
theoretical survival curves for each cell line based on the assump-
tion that the combination treatment is purely additive. This curve
was obtained by multiplying the radiation dose–surviving frac-
tions by the surviving fraction obtained following 3 min of PDT. It
can be seen that none of the cell lines exhibit survival curve para-
meters which are significantly different from these theoretical
curves. The survival curve parameters are summarised in Table 2.
DISCUSSION
This study has demonstrated the effect of photodynamic therapy
used in combination with ionising radiation on clonogenic cell
survival of head and neck tumour cell lines. Our results indicate
that under the conditions employed in this study the cumulative
effects of combined treatments are purely additive.
It has previously been shown that tumour cell sensitivity to PDT
varies during the cell cycle (Wyld et al, 1998) with cells in S-phase
and G2 being more sensitive. In the case of 5-ALA this is associ-
ated with an increased accumulation of PpIX during S-phase and
G2. There is also an inverse relationship between PpIX synthesis
and cellular iron availability (Rittenhouse-Diakun et al, 1995). S-
phase cells may be relatively iron-depleted because of intracellular
sequestration of iron by ribonucleotide reductase during DNA
synthesis (Brown et al, 1969; Reichard and Ehrenberg 1983) and
this may play a role in the increased PpIX synthesis during 
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Figure 3 Clonogenic cell survival curves for the four cell lines following
exposure to γ -irradiation
Table 1 Summary of cell characteristics and clonogenic survival data for cell lines treated with ionizing radiation or photodynamic therapy
Cell Doubling Clonogenic plating γ -radiation PDT
line time (h)a efficiency (% + 1 SE)a Ploidya SF2 α (Gy–1) (+1SE)  β (Gy–2) (+ 1 SE) SF3
VB001 nd 15.1 ± 1.2 normal diploid 0.35 0.344 ± 0.056 0.093 ± 0.009 0.54
V134 28.8 5.67 ± 0.25 polyploid 0.55 0.304 ± 0.067 0.000 ± 0.011 0.67
V175 35.7 2.82 ± 0.23 hyperdiploid 0.61 0.202 ± 0.051 0.022 ± 0.008 0.79
SCC-61 32.75 24.13 ± 1.18 hyperdiploid 0.37 0.619 ± 0.065 0.000 ± 0.011 0.68
aData from Champion et al (1997).
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Figure 4 DNA histograms of the four cell lines used in this study. Cells were
exposed to 8 Gy of ionizing radiation or 3 min of PDT or a combination of
both treatments. Data represent distributions obtained from 5000 cellsS-phase. It has further been observed that rapidly proliferating
cells with increased S-phase fractions produce more PpIX and are
more PDT-sensitive than slowly proliferating cells (Schick et al,
1995). This relationship between PDT sensitivity and growth rate
may also be due to intracellular iron regulation (Pourzand et al,
1999). These marked fluctuations in PDT sensitivity with growth
rate may account for the wide scatter observed in our measure-
ments of clonogenic cell survival following PDT.
Mitomycin C has been demonstrated to potentiate photody-
namic therapy both at the cellular level (Ma et al, 1992a, 1993a;
Datta et al, 1997) and in vivo (Baas et al, 1994, 1996). This poten-
tiation of PDT is associated with a mitomycin-C induced cell cycle
arrest in late S-phase/G2 (Ma et al, 1992b). It would therefore be
reasonable to expect that a radiation induced cell cycle arrest in G2
would also enhance the effectiveness of PDT. However, we have
found no evidence to support this hypothesis and the sensitivity of
our cell lines to PDT did not correlate with their relative accumu-
lation of PpIX. Following radiation treatment, the three tumour
cell lines used in this study (V175, V134, SCC61) exhibited a cell
cycle arrest in G2, whereas the normal fibroblasts arrested in both
G1 and G2. This observation is consistent with the suggestion that
the three tumour cell lines have aberrant p53 function (Kastan et
al, 1991, Kuerbitz et al, 1992), and it is encouraging that this does
not appear to be conferring any inherent resistance to the photody-
namic treatment.
There have been a number of previous attempts to examine the
interaction of PDT and ionizing radiation. However the results
presented are conflicting, with some authors presenting evidence
of a synergistic interaction (Boegheim et al, 1987; Kostron et al,
1986; Berg et al, 1995), while other investigations show simple
additive interaction (Bellnier and Dougherty 1986; Ben-Hur et al,
1988; Schnitzhofer and Krammer 1996). The picture is further
complicated by some studies providing evidence of a synergistic
effect or an antagonistic effect depending upon the conditions
employed within a given system (Ma et al, 1993b, Berg et al,
1995). The causes for the conflicting literature on the combination
of radiotherapy and PDT are unclear. Prinsze et al (1992)
suggested that cell line differences in the sensitivity to PDT
Photochemotherapy effect on squamous cell carcinoma 659
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Table 2 Summary of clonogenic survival data for cell lines treated with ionizing radiation followed by photodynamic therapy and vice-versa
Cell γ -Radiation + PDT PDT + γ -Radiation Theoretical
Line SF2 α (Gy–1) (+1 SE) β (Gy–2) (± 1 SE) SF2 α (Gy–1 (± 1 SE) β (Gy–2) (± 1 SE) SF2
VB001 0.07 0.00 – 0.078 0.676 ± 0.063 0.023 ± 0.012 0.114
V134 0.25 0.00 – 0.184 0.114 ± 0.091 0.046 ± 0.015 0.170
V175 0.26 0.144 ± 0.082 0.035 ± 0.014 0.327 0.00 0.060 ± 0.013 0.266
SCC-61 0.35 0.376 ± 0.070 0.011 ± 0.012 0.496 0.314 ± 0.061 0.011 ± 0.010 0.351
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Figure 5 Clonogenic cell survival curves for the four cell lines. Cells were treated with ionizing radiation, PDT followed 24 h later by ionizing radiation, or
radiation followed 24 h later by PDT. Also shown on the figure are the calculated (theoretical) survival curves assuming any combined effect to be additive in
natureinduced inhibition of DNA repair can explain the conflicting
results. Other authors (Kavarnos et al, 1994; Ma et al, 1993b; Berg
et al, 1995) suggest that the variations observed in the interaction
of PDT and ionizing radiation depend on dose and variation in
timing between the two treatments.
In vivo, photodynamic therapy is usually accompanied by
severe microvascular changes (Nelson et al, 1987) associated with
endothelial damage, microcirculatory stasis, platelet aggregation
and haemorrhage, resulting in a coagulation necrosis (Bugelski et
al, 1981; Selman et al, 1984; Star et al, 1986; Chaudhuri et al,
1987). These additional effects make it difficult to extrapolate in
vitro studies on cell lines to the clinical situation where the
combined approach of radiotherapy and photodynamic therapy
may have quite different effectiveness than that presented in this
study.
In conclusion, head and neck tumour cells were shown to accu-
mulate in G2/M phase of the cell cycle after γ -irradiation. When γ -
irradiation was combined with PDT the two treatments acted in an
additive manner regardless of the order in which they were given.
The interaction between γ -irradiation and PDT may be compli-
cated by dose and timing variations between treatments, and
further complicated by fractionated dosing of both the γ -irradiation
and PDT. These variable interactions are worthy of further investi-
gation, with a view to defining a role for combined radiotherapy
and PDT in tumour therapy.
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